Search

Products meeting the search criteria

Adair Tab

Adair Tab

Adair Tab..

Tk.15.00/=

  0 отзывов

Combair HFA Inhaler

Combair HFA Inhaler

Combair HFA Inhaler..

Tk.250.75/=

  0 отзывов

Combair HFA Refill

Combair HFA Refill

Combair HFA Refill..

Tk.230.69/=

  0 отзывов

Johnson Baby Hair Oil 100ml

Johnson Baby Hair Oil 100ml

Johnson Baby Hair Oil 100ml..

Tk.210.00/=

  0 отзывов

Johnsons Baby Hair Oil 200ml

Johnsons Baby Hair Oil 200ml

Johnsons Baby Hair Oil 200ml..

Tk.350.00/=

  0 отзывов

Montair 10 mg Tablet

Montair 10 mg Tablet

Montair 10 mg TabletDescriptionMontelukast is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene CysLT1 receptor. Cysteinyl leukotrienes and leukotriene receptor occupation have been correlated with the pathophysiology of asthma ( such as, airway edema, smooth muscle contraction and altered cellular activity associated with the inflammatory process, which contribute to the signs and symptoms of asthma).IndicationsMontelukast is indicated for the prophylaxis and chronic treatment of asthma in adults and pediatric patients from 6 months of age and older.Dosage & AdministrationAdults (15 years of age or over): 10 mg daily to be taken in the evening.Children (6-14 years of age): 5 mg daily to be taken in the evening.Children (6 months-5 years of age): 4 mg daily to be taken in the evening.Safety and effectiveness of Montelukast in pediatric patients younger than two years of age have not been established.The safety and efficacy of Montelukast was demonstrated in clinical trials where it was administered in the evening without regard to the time of food ingestion.Side EffectsGenerally, Montelukast is well-tolerated. Side effects include dizziness, headache, diarrhea, restlessness, abdominal pain, cough, fever, asthenia, rash and upper respiratory tract infection.PrecautionsMontelukast is not indicated for use in the reversal of bronchospasm in acute asthma attacks (in case of status asthmaticus).Patients with known aspirin sensitivity should continue avoidance of aspirin or other NSAID, while taking Montelukast.In rare cases, patients on therapy with Montelukast may present with systemic eosinophilia, sometimes presenting with clinical features of vasculitis consistent with churg-strauss syndrome, a condition which is often treated with systemic corticosteroid therapy. Physician should be alert to eosinophilia, vasculitic rash, worsening pulmonary symptoms, cardiac complications, and/or neuropathy presenting in their patients. A causal association between Montelukast and these underlying conditions has not been established.Use in Pregnancy & LactationPregnancy: There are no adequate and well-controlled studies of Montelukast in pregnant women. Because animal reproductive studies are not always predictive of human response, so Montelukast should be used during pregnancy only if clearly needed.Lactation: It is not known if Montelukast is excreted in human milk. Because many drugs are excreted in human milk, so caution should be exercised when Montelukast is given to a nursing mother.Drug InteractionMontelukast has been administered with other therapies routinely used in the prophylaxis and chronic treatment of asthma with no appropriate increase in adverse reactions.Cytochrome P-450 inducers: Although Phenobarbital induces hepatic metabolism, no dosage adjustment for Montelukast is recommended. It is reasonable to employ appropriate clinical monitoring when potent cytochrome P-450 enzyme inducers, such as Phenobarbital or Rifampin, are co-administered with Montelukast.Over DoseThere were no adverse experiences reported in the majority of overdosage reports. The most frequent adverse experiences observed were thirst, mydriasis, hyperkinesia, and abdominal pain. In the event of overdose, it is reasonable to employ the usual supportive measures; e.g., remove unabsorbed material from the gastrointestinal tract, employ clinical monitoring, and institute supportive therapy, if required...

Tk.16.00/=

  0 отзывов

Montair 4

Montair 4

Montair 4 TabDescriptionMontelukast is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene CysLT1 receptor. Cysteinyl leukotrienes and leukotriene receptor occupation have been correlated with the pathophysiology of asthma ( such as, airway edema, smooth muscle contraction and altered cellular activity associated with the inflammatory process, which contribute to the signs and symptoms of asthma).IndicationsMontelukast is indicated for the prophylaxis and chronic treatment of asthma in adults and pediatric patients from 6 months of age and older.Dosage & AdministrationAdults (15 years of age or over): 10 mg daily to be taken in the evening.Children (6-14 years of age): 5 mg daily to be taken in the evening.Children (6 months-5 years of age): 4 mg daily to be taken in the evening.Safety and effectiveness of Montelukast in pediatric patients younger than two years of age have not been established.The safety and efficacy of Montelukast was demonstrated in clinical trials where it was administered in the evening without regard to the time of food ingestion.Side EffectsGenerally, Montelukast is well-tolerated. Side effects include dizziness, headache, diarrhea, restlessness, abdominal pain, cough, fever, asthenia, rash and upper respiratory tract infection.PrecautionsMontelukast is not indicated for use in the reversal of bronchospasm in acute asthma attacks (in case of status asthmaticus).Patients with known aspirin sensitivity should continue avoidance of aspirin or other NSAID, while taking Montelukast.In rare cases, patients on therapy with Montelukast may present with systemic eosinophilia, sometimes presenting with clinical features of vasculitis consistent with churg-strauss syndrome, a condition which is often treated with systemic corticosteroid therapy. Physician should be alert to eosinophilia, vasculitic rash, worsening pulmonary symptoms, cardiac complications, and/or neuropathy presenting in their patients. A causal association between Montelukast and these underlying conditions has not been established.Use in Pregnancy & LactationPregnancy: There are no adequate and well-controlled studies of Montelukast in pregnant women. Because animal reproductive studies are not always predictive of human response, so Montelukast should be used during pregnancy only if clearly needed.Lactation: It is not known if Montelukast is excreted in human milk. Because many drugs are excreted in human milk, so caution should be exercised when Montelukast is given to a nursing mother.Drug InteractionMontelukast has been administered with other therapies routinely used in the prophylaxis and chronic treatment of asthma with no appropriate increase in adverse reactions.Cytochrome P-450 inducers: Although Phenobarbital induces hepatic metabolism, no dosage adjustment for Montelukast is recommended. It is reasonable to employ appropriate clinical monitoring when potent cytochrome P-450 enzyme inducers, such as Phenobarbital or Rifampin, are co-administered with Montelukast.Over DoseThere were no adverse experiences reported in the majority of overdosage reports. The most frequent adverse experiences observed were thirst, mydriasis, hyperkinesia, and abdominal pain. In the event of overdose, it is reasonable to employ the usual supportive measures; e.g., remove unabsorbed material from the gastrointestinal tract, employ clinical monitoring, and institute supportive therapy, if required...

Tk.6.00/=

  0 отзывов

Montair 5

Montair 5

Montair 5 TabDescriptionMontelukast is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene CysLT1 receptor. Cysteinyl leukotrienes and leukotriene receptor occupation have been correlated with the pathophysiology of asthma ( such as, airway edema, smooth muscle contraction and altered cellular activity associated with the inflammatory process, which contribute to the signs and symptoms of asthma).IndicationsMontelukast is indicated for the prophylaxis and chronic treatment of asthma in adults and pediatric patients from 6 months of age and older.Dosage & AdministrationAdults (15 years of age or over): 10 mg daily to be taken in the evening.Children (6-14 years of age): 5 mg daily to be taken in the evening.Children (6 months-5 years of age): 4 mg daily to be taken in the evening.Safety and effectiveness of Montelukast in pediatric patients younger than two years of age have not been established.The safety and efficacy of Montelukast was demonstrated in clinical trials where it was administered in the evening without regard to the time of food ingestion.Side EffectsGenerally, Montelukast is well-tolerated. Side effects include dizziness, headache, diarrhea, restlessness, abdominal pain, cough, fever, asthenia, rash and upper respiratory tract infection.PrecautionsMontelukast is not indicated for use in the reversal of bronchospasm in acute asthma attacks (in case of status asthmaticus).Patients with known aspirin sensitivity should continue avoidance of aspirin or other NSAID, while taking Montelukast.In rare cases, patients on therapy with Montelukast may present with systemic eosinophilia, sometimes presenting with clinical features of vasculitis consistent with churg-strauss syndrome, a condition which is often treated with systemic corticosteroid therapy. Physician should be alert to eosinophilia, vasculitic rash, worsening pulmonary symptoms, cardiac complications, and/or neuropathy presenting in their patients. A causal association between Montelukast and these underlying conditions has not been established.Use in Pregnancy & LactationPregnancy: There are no adequate and well-controlled studies of Montelukast in pregnant women. Because animal reproductive studies are not always predictive of human response, so Montelukast should be used during pregnancy only if clearly needed.Lactation: It is not known if Montelukast is excreted in human milk. Because many drugs are excreted in human milk, so caution should be exercised when Montelukast is given to a nursing mother.Drug InteractionMontelukast has been administered with other therapies routinely used in the prophylaxis and chronic treatment of asthma with no appropriate increase in adverse reactions.Cytochrome P-450 inducers: Although Phenobarbital induces hepatic metabolism, no dosage adjustment for Montelukast is recommended. It is reasonable to employ appropriate clinical monitoring when potent cytochrome P-450 enzyme inducers, such as Phenobarbital or Rifampin, are co-administered with Montelukast.Over DoseThere were no adverse experiences reported in the majority of overdosage reports. The most frequent adverse experiences observed were thirst, mydriasis, hyperkinesia, and abdominal pain. In the event of overdose, it is reasonable to employ the usual supportive measures; e.g., remove unabsorbed material from the gastrointestinal tract, employ clinical monitoring, and institute supportive therapy, if required...

Tk.8.00/=

  0 отзывов

Provair 10 mg Tab

Provair 10 mg Tab

Provair 10 mg Tab..

Tk.16.00/=

  0 отзывов

Provair 4 mg Tab

Provair 4 mg Tab

Provair 4 mg Tab..

Tk.6.00/=

  0 отзывов

Provair 5 mg Tab

Provair 5 mg Tab

Provair 5 mg Tab..

Tk.8.00/=

  0 отзывов

Reversair 10mg tab

Reversair 10mg tab

Reversair 10mg tab..

Tk.16.00/=

  0 отзывов

Reversair 4 Tab

Reversair 4 Tab

Reversair 4 Tab..

Tk.7.05/=

  0 отзывов

Reversair 5 od tab

Reversair 5 od tab

Reversair 5 od tab..

Tk.8.05/=

  0 отзывов

Roxair Tab

Roxair Tab

Roxair Tab..

Tk.15.00/=

  0 отзывов

Spring Air Fresher Lemon 300ml

Spring Air Fresher Lemon 300ml

Spring Air Fresher Lemon 300ml..

Tk.215.00/=

  0 отзывов

Spring Air Fresher Orange 300ml

Spring Air Fresher Orange 300ml

Spring Air Fresher Orange 300ml..

Tk.215.00/=

  0 отзывов

AMLA Hair Oil130ml

AMLA Hair Oil130ml

Price৳ 135 TKNameAMLA Hair OilGenericPhyllanthus emblica l .66ml, Sesamum indicum 3.33ml, other ingredients q.s.TypeLiquidQuantity1's packDose130ml..

Tk.200.00/=

  0 отзывов

Hairgrow 5% 60 ml Hand Wash

Hairgrow 5% 60 ml Hand Wash

Hairgrow 5% 60 ml Hand Wash..

Tk.600.00/=

  0 отзывов

Hairgrow 60 ml Hand Wash

Hairgrow 60 ml Hand Wash

Hairgrow 2% Hand Wash,60 ml bottle..

Tk.500.00/=

  0 отзывов

Jui Hair Care Oil 100 ml

Jui Hair Care Oil 100 ml

..

Tk.85.00/=

  0 отзывов

Jui Hair Care Oil 200 ml

Jui Hair Care Oil 200 ml

..

Tk.155.00/=

  0 отзывов

Jui Hair Care Oil 350 ml

Jui Hair Care Oil 350 ml

..

Tk.240.00/=

  0 отзывов

Jui Pure Cocoanut Oil (Plastic) 100 ml

Jui Pure Cocoanut Oil (Plastic) 100 ml

..

Tk.70.00/=

  0 отзывов

Jui Pure Cocoanut Oil (Plastic) 200 ml

Jui Pure Cocoanut Oil (Plastic) 200 ml

..

Tk.130.00/=

  0 отзывов

Jui Pure Cocoanut Oil (Plastic) 350 ml

Jui Pure Cocoanut Oil (Plastic) 350 ml

..

Tk.210.00/=

  0 отзывов

Jui Pure Cocoanut Oil (Tin) 200 ml

Jui Pure Cocoanut Oil (Tin) 200 ml

..

Tk.130.00/=

  0 отзывов

Jui Pure Cocoanut Oil (Tin) 350 ml

Jui Pure Cocoanut Oil (Tin) 350 ml

..

Tk.210.00/=

  0 отзывов

Levair 100 ml Syrup

Levair 100 ml Syrup

Levair 1 mg/5 ml Syrup,100 ml..

Tk.35.24/=

  0 отзывов

Montair 4 ODT

Montair 4 ODT

Montair 4 ODT Tablet  DescriptionMontelukast is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene CysLT1 receptor. Cysteinyl leukotrienes and leukotriene receptor occupation have been correlated with the pathophysiology of asthma ( such as, airway edema, smooth muscle contraction and altered cellular activity associated with the inflammatory process, which contribute to the signs and symptoms of asthma).IndicationsMontelukast is indicated for the prophylaxis and chronic treatment of asthma in adults and pediatric patients from 6 months of age and older.Dosage & AdministrationAdults (15 years of age or over): 10 mg daily to be taken in the evening.Children (6-14 years of age): 5 mg daily to be taken in the evening.Children (6 months-5 years of age): 4 mg daily to be taken in the evening.Safety and effectiveness of Montelukast in pediatric patients younger than two years of age have not been established.The safety and efficacy of Montelukast was demonstrated in clinical trials where it was administered in the evening without regard to the time of food ingestion.Side EffectsGenerally, Montelukast is well-tolerated. Side effects include dizziness, headache, diarrhea, restlessness, abdominal pain, cough, fever, asthenia, rash and upper respiratory tract infection.PrecautionsMontelukast is not indicated for use in the reversal of bronchospasm in acute asthma attacks (in case of status asthmaticus).Patients with known aspirin sensitivity should continue avoidance of aspirin or other NSAID, while taking Montelukast.In rare cases, patients on therapy with Montelukast may present with systemic eosinophilia, sometimes presenting with clinical features of vasculitis consistent with churg-strauss syndrome, a condition which is often treated with systemic corticosteroid therapy. Physician should be alert to eosinophilia, vasculitic rash, worsening pulmonary symptoms, cardiac complications, and/or neuropathy presenting in their patients. A causal association between Montelukast and these underlying conditions has not been established.Use in Pregnancy & LactationPregnancy: There are no adequate and well-controlled studies of Montelukast in pregnant women. Because animal reproductive studies are not always predictive of human response, so Montelukast should be used during pregnancy only if clearly needed.Lactation: It is not known if Montelukast is excreted in human milk. Because many drugs are excreted in human milk, so caution should be exercised when Montelukast is given to a nursing mother.Drug InteractionMontelukast has been administered with other therapies routinely used in the prophylaxis and chronic treatment of asthma with no appropriate increase in adverse reactions.Cytochrome P-450 inducers: Although Phenobarbital induces hepatic metabolism, no dosage adjustment for Montelukast is recommended. It is reasonable to employ appropriate clinical monitoring when potent cytochrome P-450 enzyme inducers, such as Phenobarbital or Rifampin, are co-administered with Montelukast.Over DoseThere were no adverse experiences reported in the majority of overdosage reports. The most frequent adverse experiences observed were thirst, mydriasis, hyperkinesia, and abdominal pain. In the event of overdose, it is reasonable to employ the usual supportive measures; e.g., remove unabsorbed material from the gastrointestinal tract, employ clinical monitoring, and institute supportive therapy, if required...

Tk.7.00/=

  0 отзывов

Montair 5 ODT

Montair 5 ODT

Montair 5 ODT TabletDescriptionMontelukast is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene CysLT1 receptor. Cysteinyl leukotrienes and leukotriene receptor occupation have been correlated with the pathophysiology of asthma ( such as, airway edema, smooth muscle contraction and altered cellular activity associated with the inflammatory process, which contribute to the signs and symptoms of asthma).IndicationsMontelukast is indicated for the prophylaxis and chronic treatment of asthma in adults and pediatric patients from 6 months of age and older.Dosage & AdministrationAdults (15 years of age or over): 10 mg daily to be taken in the evening.Children (6-14 years of age): 5 mg daily to be taken in the evening.Children (6 months-5 years of age): 4 mg daily to be taken in the evening.Safety and effectiveness of Montelukast in pediatric patients younger than two years of age have not been established.The safety and efficacy of Montelukast was demonstrated in clinical trials where it was administered in the evening without regard to the time of food ingestion.Side EffectsGenerally, Montelukast is well-tolerated. Side effects include dizziness, headache, diarrhea, restlessness, abdominal pain, cough, fever, asthenia, rash and upper respiratory tract infection.PrecautionsMontelukast is not indicated for use in the reversal of bronchospasm in acute asthma attacks (in case of status asthmaticus).Patients with known aspirin sensitivity should continue avoidance of aspirin or other NSAID, while taking Montelukast.In rare cases, patients on therapy with Montelukast may present with systemic eosinophilia, sometimes presenting with clinical features of vasculitis consistent with churg-strauss syndrome, a condition which is often treated with systemic corticosteroid therapy. Physician should be alert to eosinophilia, vasculitic rash, worsening pulmonary symptoms, cardiac complications, and/or neuropathy presenting in their patients. A causal association between Montelukast and these underlying conditions has not been established.Use in Pregnancy & LactationPregnancy: There are no adequate and well-controlled studies of Montelukast in pregnant women. Because animal reproductive studies are not always predictive of human response, so Montelukast should be used during pregnancy only if clearly needed.Lactation: It is not known if Montelukast is excreted in human milk. Because many drugs are excreted in human milk, so caution should be exercised when Montelukast is given to a nursing mother.Drug InteractionMontelukast has been administered with other therapies routinely used in the prophylaxis and chronic treatment of asthma with no appropriate increase in adverse reactions.Cytochrome P-450 inducers: Although Phenobarbital induces hepatic metabolism, no dosage adjustment for Montelukast is recommended. It is reasonable to employ appropriate clinical monitoring when potent cytochrome P-450 enzyme inducers, such as Phenobarbital or Rifampin, are co-administered with Montelukast.Over DoseThere were no adverse experiences reported in the majority of overdosage reports. The most frequent adverse experiences observed were thirst, mydriasis, hyperkinesia, and abdominal pain. In the event of overdose, it is reasonable to employ the usual supportive measures; e.g., remove unabsorbed material from the gastrointestinal tract, employ clinical monitoring, and institute supportive therapy, if required...

Tk.8.00/=

  0 отзывов

PROVAIR 4mg Chew. Tab.

PROVAIR 4mg Chew. Tab.

Montelukast sodium INN 4mg & 5mg/tablet 4mg x 30's pack: 180.00 MRP....

Tk.180.00/=

  0 отзывов

PROVAIR 5mg Chew. Tab.

PROVAIR 5mg Chew. Tab.

Montelukast sodium INN 4mg & 5mg/tablet5mg x 30's pack: 240.00 MRP....

Tk.240.00/=

  0 отзывов

PROVAIR-10 Tab.

PROVAIR-10 Tab.

Montelukast sodium INN 10mg/tablet10mg x 30's pack: 450.00 MRP....

Tk.450.00/=

  0 отзывов

Spring Air Freshener (Anti Tobacco)

Spring Air Freshener (Anti Tobacco)

..

Tk.215.00/=

  0 отзывов

Spring Air Freshener (Floral Fresh)

Spring Air Freshener (Floral Fresh)

..

Tk.215.00/=

  0 отзывов

Spring Air Freshener (Lemon Grass)

Spring Air Freshener (Lemon Grass)

..

Tk.215.00/=

  0 отзывов

Spring Air Freshener Odor Block (Lavender)

Spring Air Freshener Odor Block (Lavender)

..

Tk.40.00/=

  0 отзывов

Spring Air Freshener Odor Block (Rajanigandha)

Spring Air Freshener Odor Block (Rajanigandha)

..

Tk.40.00/=

  0 отзывов

Spring Air Freshener Odor Block (Rose)

Spring Air Freshener Odor Block (Rose)

..

Tk.40.00/=

  0 отзывов

Xolair 150 mg/vial Injection

Xolair 150 mg/vial Injection

Xolair 150 mg/vial Injection..

Tk.38,143.88/=

  0 отзывов

Showing 1 to 41 of 41 (1 Pages)